Royal Bank of Canada’s Assembly Biosciences ASMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12K | Buy |
440
+424
| +2,650% | +$11.5K | ﹤0.01% | 6568 |
|
|
2026
Q1 | $0 | Buy |
+16
| New | +$456 | ﹤0.01% | 7086 |
|
|
2025
Q3 | – | Sell |
-53
| Closed | -$1K | – | 7108 |
|
|
2025
Q2 | $1K | Buy |
+53
| New | +$699 | ﹤0.01% | 6849 |
|
|
2024
Q2 | – | Sell |
-79
| Closed | -$1K | – | 7017 |
|
|
2024
Q1 | $1K | Buy |
79
+33
| +72% | +$385 | ﹤0.01% | 6750 |
|
|
2023
Q4 | $0 | Buy |
+46
| New | +$437 | ﹤0.01% | 7084 |
|
|
2023
Q3 | – | Sell |
-28
| Closed | – | – | 7057 |
|
|
2023
Q2 | $0 | Buy |
+28
| New | +$344 | ﹤0.01% | 7225 |
|
|
2022
Q4 | – | Sell |
-16
| Closed | – | – | 7201 |
|
|
2022
Q3 | $0 | Buy |
+16
| New | +$387 | ﹤0.01% | 7422 |
|
|
2022
Q1 | – | Sell |
-2
| Closed | – | – | 7717 |
|
|
2021
Q4 | $0 | Buy |
+2
| New | +$66 | ﹤0.01% | 7636 |
|
|
2021
Q3 | – | Sell |
-860
| Closed | -$40K | – | 7611 |
|
|
2021
Q2 | $40K | Buy |
860
+559
| +186% | +$27.7K | ﹤0.01% | 6179 |
|
|
2021
Q1 | $16K | Buy |
301
+143
| +91% | +$9.48K | ﹤0.01% | 6552 |
|
|
2020
Q4 | $12K | Buy |
158
+133
| +532% | +$15.6K | ﹤0.01% | 6290 |
|
|
2020
Q3 | $5K | Sell |
25
-85
| -77% | -$21.4K | ﹤0.01% | 6124 |
|
|
2020
Q2 | $31K | Buy |
110
+73
| +197% | +$17K | ﹤0.01% | 5412 |
|
|
2020
Q1 | $7K | Sell |
37
-88
| -70% | -$18.9K | ﹤0.01% | 5927 |
|
|
2019
Q4 | $30K | Buy |
125
+100
| +400% | +$18.4K | ﹤0.01% | 5679 |
|
|
2019
Q3 | $3K | Sell |
25
-1
| -4% | -$151 | ﹤0.01% | 6175 |
|
|
2019
Q2 | $4K | Buy |
26
+1
| +4% | +$190 | ﹤0.01% | 6372 |
|
|
2019
Q1 | $6K | Hold |
25
| – | – | ﹤0.01% | 6180 |
|
|
2018
Q4 | $7K | Sell |
25
-28
| -53% | -$8.1K | ﹤0.01% | 6020 |
|
|
2018
Q3 | $23K | Buy |
53
+28
| +112% | +$13.1K | ﹤0.01% | 5597 |
|
|
2018
Q2 | $12K | Sell |
25
-10
| -29% | -$5.29K | ﹤0.01% | 5758 |
|
|
2018
Q1 | $21K | Buy |
35
+10
| +40% | +$6.2K | ﹤0.01% | 5426 |
|
|
2017
Q4 | $14K | Sell |
25
-100
| -80% | -$45.3K | ﹤0.01% | 5729 |
|
|
2017
Q3 | $52K | Buy |
125
+100
| +400% | +$30.6K | ﹤0.01% | 5383 |
|
|
2017
Q2 | $6K | Hold |
25
| – | – | ﹤0.01% | 5969 |
|
|
2017
Q1 | $8K | Buy |
+25
| New | +$6.13K | ﹤0.01% | 6053 |
|
|
2015
Q4 | – | Sell |
-48
| Closed | -$5K | – | 6616 |
|
|
2015
Q3 | $5K | Sell |
48
-18
| -27% | -$3.17K | ﹤0.01% | 6150 |
|
|
2015
Q2 | $15K | Buy |
+66
| New | +$12.7K | ﹤0.01% | 5848 |
|
|
2013
Q3 | – | Sell |
-3
| Closed | – | – | 6072 |
|
|
2013
Q2 | $0 | Buy |
+3
| New | +$470 | ﹤0.01% | 5818 |
|
Other funds holding ASMB
GS
FCM
PBA
CC
RCM
JT
PHP
Royal Bank of Canada's ASMB Position: Q2 2026 in Review
Royal Bank of Canada increased its Assembly Biosciences (ASMB) stake by 2,650% in Q2 2026, buying an estimated $11.5K and bringing the position to 440 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #6568.
Royal Bank of Canada first reported a position in ASMB in Q2 2013 and has held it in 29 quarters since. The position peaked at $52K in Q3 2017. 93 funds tracked by Wall St. Rank hold ASMB as of Q2 2026.
- Royal Bank of Canada held 440 shares of Assembly Biosciences worth $12K as of Q2 2026.
- Royal Bank of Canada bought 424 Assembly Biosciences shares in Q2 2026, an estimated $11.5K.
- Assembly Biosciences made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #6568 holding.
- Royal Bank of Canada first reported a position in Assembly Biosciences in Q2 2013 and has held it in 29 quarters since.
- Royal Bank of Canada's Assembly Biosciences position peaked at $52K in Q3 2017.
- 93 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2026.
Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.